Global Polio Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 85

Published Date: 05 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Polio Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Polio Vaccine size is estimated to be XX million in 2021 from USD 688.9 million in 2020, with a change of XX% between 2020 and 2021. The global Polio Vaccine market size is expected to grow at a CAGR of 4.0% for the next five years.

Market segmentation
Polio Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Inactivated Polio Vaccine (IPV)
    Oral Polio Vaccine (OPV)

Market segment by Application can be divided into
    Public
    Private

The key market players for global Polio Vaccine market are listed below:
    Sanofi
    GSK
    Bibcol
    Serum Institute
    Tiantan Biological
    IMBCA
    Panacea Biotec Ltd
    Bio-Med
    Halfkin Bio-Pharmaceuticals

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Polio Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Polio Vaccine, with price, sales, revenue and global market share of Polio Vaccine from 2019 to 2021.
Chapter 3, the Polio Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polio Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Polio Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Polio Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Polio Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Polio Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Inactivated Polio Vaccine (IPV)
        1.2.3 Oral Polio Vaccine (OPV)
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Polio Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Public
        1.3.3 Private
    1.4 Global Polio Vaccine Market Size & Forecast
        1.4.1 Global Polio Vaccine Sales in Value (2016-2026))
        1.4.2 Global Polio Vaccine Sales in Volume (2016-2026)
        1.4.3 Global Polio Vaccine Price by Type (2016-2026) & (USD/K Doses)
    1.5 Global Polio Vaccine Production Capacity Analysis
        1.5.1 Global Polio Vaccine Total Production Capacity (2016-2026)
        1.5.2 Global Polio Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Polio Vaccine Market Drivers
        1.6.2 Polio Vaccine Market Restraints
        1.6.3 Polio Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Polio Vaccine Product and Services
        2.1.4 Sanofi Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Polio Vaccine Product and Services
        2.2.4 GSK Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Bibcol
        2.3.1 Bibcol Details
        2.3.2 Bibcol Major Business
        2.3.3 Bibcol Polio Vaccine Product and Services
        2.3.4 Bibcol Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Serum Institute
        2.4.1 Serum Institute Details
        2.4.2 Serum Institute Major Business
        2.4.3 Serum Institute Polio Vaccine Product and Services
        2.4.4 Serum Institute Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Tiantan Biological
        2.5.1 Tiantan Biological Details
        2.5.2 Tiantan Biological Major Business
        2.5.3 Tiantan Biological Polio Vaccine Product and Services
        2.5.4 Tiantan Biological Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 IMBCA
        2.6.1 IMBCA Details
        2.6.2 IMBCA Major Business
        2.6.3 IMBCA Polio Vaccine Product and Services
        2.6.4 IMBCA Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Panacea Biotec Ltd
        2.7.1 Panacea Biotec Ltd Details
        2.7.2 Panacea Biotec Ltd Major Business
        2.7.3 Panacea Biotec Ltd Polio Vaccine Product and Services
        2.7.4 Panacea Biotec Ltd Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Bio-Med
        2.8.1 Bio-Med Details
        2.8.2 Bio-Med Major Business
        2.8.3 Bio-Med Polio Vaccine Product and Services
        2.8.4 Bio-Med Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Halfkin Bio-Pharmaceuticals
        2.9.1 Halfkin Bio-Pharmaceuticals Details
        2.9.2 Halfkin Bio-Pharmaceuticals Major Business
        2.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
        2.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Polio Vaccine Sales by Manufacturer
    3.1 Global Polio Vaccine Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Polio Vaccine Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Polio Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Polio Vaccine Manufacturer Market Share
        3.4.2 Top 6 Polio Vaccine Manufacturer Market Share
    3.5 Global Polio Vaccine Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Polio Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Polio Vaccine Market Size by Region
        4.1.1 Global Polio Vaccine Sales in Volume by Region (2016-2026)
        4.1.2 Global Polio Vaccine Revenue by Region (2016-2026)
    4.2 North America Polio Vaccine Revenue (2016-2026)
    4.3 Europe Polio Vaccine Revenue (2016-2026)
    4.4 Asia-Pacific Polio Vaccine Revenue (2016-2026)
    4.5 South America Polio Vaccine Revenue (2016-2026)
    4.6 Middle East and Africa Polio Vaccine Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Polio Vaccine Sales in Volume by Type (2016-2026)
    5.2 Global Polio Vaccine Revenue by Type (2016-2026)
    5.3 Global Polio Vaccine Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Polio Vaccine Sales in Volume by Application (2016-2026)
    6.2 Global Polio Vaccine Revenue by Application (2016-2026)
    6.3 Global Polio Vaccine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Polio Vaccine Sales by Type (2016-2026)
    7.2 North America Polio Vaccine Sales by Application (2016-2026)
    7.3 North America Polio Vaccine Market Size by Country
        7.3.1 North America Polio Vaccine Sales in Volume by Country (2016-2026)
        7.3.2 North America Polio Vaccine Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Polio Vaccine Sales by Type (2016-2026)
    8.2 Europe Polio Vaccine Sales by Application (2016-2026)
    8.3 Europe Polio Vaccine Market Size by Country
        8.3.1 Europe Polio Vaccine Sales in Volume by Country (2016-2026)
        8.3.2 Europe Polio Vaccine Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Polio Vaccine Sales by Type (2016-2026)
    9.2 Asia-Pacific Polio Vaccine Sales by Application (2016-2026)
    9.3 Asia-Pacific Polio Vaccine Market Size by Region
        9.3.1 Asia-Pacific Polio Vaccine Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Polio Vaccine Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Polio Vaccine Sales by Type (2016-2026)
    10.2 South America Polio Vaccine Sales by Application (2016-2026)
    10.3 South America Polio Vaccine Market Size by Country
        10.3.1 South America Polio Vaccine Sales in Volume by Country (2016-2026)
        10.3.2 South America Polio Vaccine Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Polio Vaccine Sales by Type (2016-2026)
    11.2 Middle East & Africa Polio Vaccine Sales by Application (2016-2026)
    11.3 Middle East & Africa Polio Vaccine Market Size by Country
        11.3.1 Middle East & Africa Polio Vaccine Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Polio Vaccine Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Polio Vaccine Typical Distributors
    12.3 Polio Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Polio Vaccine Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Polio Vaccine Revenue by Application, (USD Million), 2021-2026
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Polio Vaccine Product and Services
    Table 6. Sanofi Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. GSK Basic Information, Manufacturing Base and Competitors
    Table 8. GSK Major Business
    Table 9. GSK Polio Vaccine Product and Services
    Table 10. GSK Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Bibcol Basic Information, Manufacturing Base and Competitors
    Table 12. Bibcol Major Business
    Table 13. Bibcol Polio Vaccine Product and Services
    Table 14. Bibcol Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Serum Institute Basic Information, Manufacturing Base and Competitors
    Table 16. Serum Institute Major Business
    Table 17. Serum Institute Polio Vaccine Product and Services
    Table 18. Serum Institute Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Tiantan Biological Basic Information, Manufacturing Base and Competitors
    Table 20. Tiantan Biological Major Business
    Table 21. Tiantan Biological Polio Vaccine Product and Services
    Table 22. Tiantan Biological Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. IMBCA Basic Information, Manufacturing Base and Competitors
    Table 24. IMBCA Major Business
    Table 25. IMBCA Polio Vaccine Product and Services
    Table 26. IMBCA Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
    Table 28. Panacea Biotec Ltd Major Business
    Table 29. Panacea Biotec Ltd Polio Vaccine Product and Services
    Table 30. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Bio-Med Basic Information, Manufacturing Base and Competitors
    Table 32. Bio-Med Major Business
    Table 33. Bio-Med Polio Vaccine Product and Services
    Table 34. Bio-Med Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 36. Halfkin Bio-Pharmaceuticals Major Business
    Table 37. Halfkin Bio-Pharmaceuticals Polio Vaccine Product and Services
    Table 38. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Global Polio Vaccine Sales by Manufacturer (2019-2021e) & (M Doses)
    Table 40. Global Polio Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 41. Market Position of Manufacturers in Polio Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 42. Global Polio Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
    Table 43. Head Office and Polio Vaccine Production Site of Key Manufacturer
    Table 44. Polio Vaccine New Entrant and Capacity Expansion Plans
    Table 45. Polio Vaccine Mergers & Acquisitions in the Past Five Years
    Table 46. Global Polio Vaccine Sales by Region (2016-2021e) & (M Doses)
    Table 47. Global Polio Vaccine Sales by Region (2021-2026) & (M Doses)
    Table 48. Global Polio Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 49. Global Polio Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 50. Global Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 51. Global Polio Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 52. Global Polio Vaccine Revenue by Type (2016-2021e) & (USD Million)
    Table 53. Global Polio Vaccine Revenue by Type (2021-2026) & (USD Million)
    Table 54. Global Polio Vaccine Price by Type (2016-2021e) & (USD/K Doses)
    Table 55. Global Polio Vaccine Price by Type (2021-2026) & (USD/K Doses)
    Table 56. Global Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 57. Global Polio Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 58. Global Polio Vaccine Revenue by Application (2016-2021e) & (USD Million)
    Table 59. Global Polio Vaccine Revenue by Application (2021-2026) & (USD Million)
    Table 60. Global Polio Vaccine Price by Application (2016-2021e) & (USD/K Doses)
    Table 61. Global Polio Vaccine Price by Application (2021-2026) & (USD/K Doses)
    Table 62. North America Polio Vaccine Sales by Country (2016-2021e) & (M Doses)
    Table 63. North America Polio Vaccine Sales by Country (2021-2026) & (M Doses)
    Table 64. North America Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 65. North America Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 66. North America Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 67. North America Polio Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 68. North America Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 69. North America Polio Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 70. Europe Polio Vaccine Sales by Country (2016-2021e) & (M Doses)
    Table 71. Europe Polio Vaccine Sales by Country (2021-2026) & (M Doses)
    Table 72. Europe Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 73. Europe Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 74. Europe Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 75. Europe Polio Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 76. Europe Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 77. Europe Polio Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 78. Asia-Pacific Polio Vaccine Sales by Region (2016-2021e) & (M Doses)
    Table 79. Asia-Pacific Polio Vaccine Sales by Region (2021-2026) & (M Doses)
    Table 80. Asia-Pacific Polio Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 81. Asia-Pacific Polio Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 82. Asia-Pacific Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 83. Asia-Pacific Polio Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 84. Asia-Pacific Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 85. Asia-Pacific Polio Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 86. South America Polio Vaccine Sales by Country (2016-2021e) & (M Doses)
    Table 87. South America Polio Vaccine Sales by Country (2021-2026) & (M Doses)
    Table 88. South America Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 89. South America Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 90. South America Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 91. South America Polio Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 92. South America Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 93. South America Polio Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 94. Middle East & Africa Polio Vaccine Sales by Country (2016-2021e) & (M Doses)
    Table 95. Middle East & Africa Polio Vaccine Sales by Country (2021-2026) & (M Doses)
    Table 96. Middle East & Africa Polio Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 97. Middle East & Africa Polio Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 98. Middle East & Africa Polio Vaccine Sales by Type (2016-2021e) & (M Doses)
    Table 99. Middle East & Africa Polio Vaccine Sales by Type (2021-2026) & (M Doses)
    Table 100. Middle East & Africa Polio Vaccine Sales by Application (2016-2021e) & (M Doses)
    Table 101. Middle East & Africa Polio Vaccine Sales by Application (2021-2026) & (M Doses)
    Table 102. Direct Channel Pros & Cons
    Table 103. Indirect Channel Pros & Cons
    Table 104. Polio Vaccine Typical Distributors
    Table 105. Polio Vaccine Typical Customers
List of Figures
    Figure 1. Polio Vaccine Picture
    Figure 2. Global Polio Vaccine Sales Market Share by Type in 2020
    Figure 3. Inactivated Polio Vaccine (IPV)
    Figure 4. Oral Polio Vaccine (OPV)
    Figure 5. Global Polio Vaccine Sales Market Share by Application in 2020
    Figure 6. Public
    Figure 7. Private
    Figure 8. Global Polio Vaccine Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
    Figure 9. Global Polio Vaccine Market Size and Forecast (2016-2026) & (USD Million)
    Figure 10. Global Polio Vaccine Sales (2016-2026) & (M Doses)
    Figure 11. Global Polio Vaccine Price by Type (2016-2026) & (USD/K Doses)
    Figure 12. Global Polio Vaccine Production Capacity (2016-2026) & (M Doses)
    Figure 13. Global Polio Vaccine Production Capacity by Geographic Region: 2020 VS 2021
    Figure 14. Polio Vaccine Market Drivers
    Figure 15. Polio Vaccine Market Restraints
    Figure 16. Polio Vaccine Market Trends
    Figure 17. Global Polio Vaccine Sales Market Share by Manufacturer in 2020
    Figure 18. Global Polio Vaccine Revenue Market Share by Manufacturer in 2020
    Figure 19. Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 20. Top 3 Polio Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 21. Top 6 Polio Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 22. Global Polio Vaccine Sales Market Share by Region (2016-2026)
    Figure 23. Global Polio Vaccine Revenue Market Share by Region (2016-2026)
    Figure 24. North America Polio Vaccine Revenue (2016-2026) & (USD Million)
    Figure 25. Europe Polio Vaccine Revenue (2016-2026) & (USD Million)
    Figure 26. Asia-Pacific Polio Vaccine Revenue (2016-2026) & (USD Million)
    Figure 27. South America Polio Vaccine Revenue (2016-2026) & (USD Million)
    Figure 28. Middle East & Africa Polio Vaccine Revenue (2016-2026) & (USD Million)
    Figure 29. Global Polio Vaccine Sales Market Share by Type (2016-2026)
    Figure 30. Global Polio Vaccine Revenue Market Share by Type (2016-2026)
    Figure 31. Global Polio Vaccine Price by Type (2016-2026) & (USD/K Doses)
    Figure 32. Global Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 33. Global Polio Vaccine Revenue Market Share by Application (2016-2026)
    Figure 34. Global Polio Vaccine Price by Application (2016-2026) & (USD/K Doses)
    Figure 35. North America Polio Vaccine Sales Market Share by Type (2016-2026)
    Figure 36. North America Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 37. North America Polio Vaccine Sales Market Share by Country (2016-2026)
    Figure 38. North America Polio Vaccine Revenue Market Share by Country (2016-2026)
    Figure 39. United States Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 40. Canada Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 41. Mexico Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Europe Polio Vaccine Sales Market Share by Type (2016-2026)
    Figure 43. Europe Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 44. Europe Polio Vaccine Sales Market Share by Country (2016-2026)
    Figure 45. Europe Polio Vaccine Revenue Market Share by Country (2016-2026)
    Figure 46. Germany Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. France Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. United Kingdom Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Russia Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Italy Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Asia-Pacific Polio Vaccine Sales Market Share by Region (2016-2026)
    Figure 52. Asia-Pacific Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 53. Asia-Pacific Polio Vaccine Sales Market Share by Region (2016-2026)
    Figure 54. Asia-Pacific Polio Vaccine Revenue Market Share by Region (2016-2026)
    Figure 55. China Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Japan Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Korea Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. India Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Southeast Asia Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Australia Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. South America Polio Vaccine Sales Market Share by Type (2016-2026)
    Figure 62. South America Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 63. South America Polio Vaccine Sales Market Share by Country (2016-2026)
    Figure 64. South America Polio Vaccine Revenue Market Share by Country (2016-2026)
    Figure 65. Brazil Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Argentina Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Middle East & Africa Polio Vaccine Sales Market Share by Type (2016-2026)
    Figure 68. Middle East & Africa Polio Vaccine Sales Market Share by Application (2016-2026)
    Figure 69. Middle East & Africa Polio Vaccine Sales Market Share by Country (2016-2026)
    Figure 70. Middle East & Africa Polio Vaccine Revenue Market Share by Country (2016-2026)
    Figure 71. Turkey Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Egypt Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Saudi Arabia Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. South Africa Polio Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Sales Channel: Direct Channel vs Indirect Channel
    Figure 76. Methodology
    Figure 77. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Related Reports

Global Polio Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Polio Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

The Polio Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Polio Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Polio Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

Global Polio Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Polio Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Polio Vaccine market size was valued at USD 730.3 million in 2023 and is forecast to a readjusted size of USD 962.3 million by 2030 with a CAGR of 4.0% during review period.

Product Tags

polio vaccine

inactivated polio vaccine

sabin inactivated polio vaccine sipv

Sabin Inactivated Polio vaccine (sIPV)

Live Attenuated Polio Vaccine

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>